Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBASP vs. BA in Persistently Depressed Treatment-resistant Inpatients
NCT04996433Recruiting
- Sponsor
- University of Greifswald
- Start
- Dec 2021
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Randomised trial in persistent depressive disorder (PDD) and treatment-resistant depression (TRD) (2 arms), sponsored by University of Greifswald. Primary endpoint: Hamilton Depression Rating Scale, 24-item version at 16 weeks. Started Dec 2021; status: recruiting.
02
Conditions
persistent depressive disorder (PDD)treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NCT04996433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04996433.